Form D · Biotechnology
Securus Medical Group, Inc.
Cleveland, OH · CIK 0001525316
Offering snapshot reported Dec 11, 2013 · SEC filing
- Reported sold
- $6.5M Offering amount: $6.5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 7, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 11, 2013 | Initial | $6,500,000 | No comparison | 4 | SEC filing |
| Jul 11, 2011 | Initial | $500,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-207832
Source: Form D, filed Dec 11, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Adaniya | Director |
| Christopher Flaherty | Promoter |
| John Garibotto | Executive, Promoter |
| Steven Girouard | Director, Executive |
| Donna Richardson | Director, Executive |
| Karen Spilizewski | Director |
| Nicholas Walrod | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10000 Cedar Avenue Mailstop #22
Cleveland, OH, 44106
Cleveland, OH, 44106